Seeing Is Believing
BHVN is currently covered by 6 analysts with an average price target of $67.02. This is a potential upside of $17.12 (34.31%) from yesterday's end of day stock price of $49.9.
Biohaven Pharmaceutical Holding Co Ltd's activity chart (see below) currently has 3 price targets and 33 ratings on display. The stock rating distribution of BHVN is 100% BUY.
Analysts average stock forecasts to be materialized ratio is 95.06% with an average time for these price targets to be met of 192.07 days.
Highest price target for BHVN is $76, Lowest price target is $35, average price target is $67.02.
Most recent stock forecast was given by CHARLES DUNCAN from CANTOR FITZGERALD on 23-Oct-2024. First documented stock forecast 12-Oct-2022.
Currently out of the existing stock ratings of BHVN, 31 are a BUY (100%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
13 days ago
(23-Oct-2024)
2/2 (100%)
$4.59 (17.38%)
185
Buy
$68
$17.12 (33.65%)
$56
1 months 2 days ago
(03-Oct-2024)
7/8 (87.5%)
$20.27 (42.47%)
56
Buy
$76
$25.12 (49.37%)
$36
1 months 13 days ago
(23-Sep-2024)
4/5 (80%)
$30.8 (68.14%)
158
Buy
$59
$8.12 (15.96%)
$37
9 months 27 days ago
(09-Jan-2024)
4/4 (100%)
$11.29 (23.66%)
108
Buy
$35
$-15.88 (-31.21%)
$25
11 months 21 days ago
(15-Nov-2023)
2/2 (100%)
$5.95 (20.48%)
137
What is BHVN (Biohaven Pharmaceutical Holding Co Ltd) average time for price targets to be met?
Which analyst has the current highest performing score on BHVN (Biohaven Pharmaceutical Holding Co Ltd) with a proven track record?
Which analyst has the most public recommendations on BHVN (Biohaven Pharmaceutical Holding Co Ltd)?
Which analyst is the currently most bullish on BHVN (Biohaven Pharmaceutical Holding Co Ltd)?
Which analyst is the currently most reserved on BHVN (Biohaven Pharmaceutical Holding Co Ltd)?